GCM
SMTI icon

Gladius Capital Management’s Sanara MedTech SMTI Stock Holding History

Gladius Capital Management’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,104
Closed -$45.4K – 408
2023
Q4 		$45.4K Buy
+1,104
New +$35.4K 0.01% 188

Other funds holding SMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

Gladius Capital Management's SMTI Position: Q1 2024 in Review

Gladius Capital Management sold out of Sanara MedTech (SMTI) in Q1 2024, closing a stake of 1,104 shares — an estimated $45.4K sold.

Gladius Capital Management first reported a position in SMTI in Q4 2023 and held it in 1 quarter. The position peaked at $45.4K in Q4 2023. 43 funds tracked by Wall St. Rank hold SMTI as of Q1 2024.

  • Gladius Capital Management reported no remaining Sanara MedTech position as of Q1 2024 after selling out during the quarter.
  • Gladius Capital Management sold 1,104 Sanara MedTech shares in Q1 2024, an estimated $45.4K.
  • Gladius Capital Management first reported a position in Sanara MedTech in Q4 2023 and held it in 1 quarter.
  • Gladius Capital Management's Sanara MedTech position peaked at $45.4K in Q4 2023.
  • 43 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2024.

Based on Gladius Capital Management's 13F filing for Q1 2024, filed 14 May 2024.